Dr. Pecot on Immunotherapy Combinations in NSCLC – OncLive
|
Dr. Pecot on Immunotherapy Combinations in NSCLC
OncLive Chad Pecot, MD, assistant professor, School of Medicine, UNC Lineberger Comprehensive Cancer Center, discusses promising combinations for patients with non–small cell lung cancer (NSCLC). IDO inhibitors plus nivolumab (Opdivo) and pembrolizumab … |
